Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Daiichi Sankyo to restructure Asubio Pharma subsidiary
April 2009
SHARING OPTIONS:

TOKYO—Daiichi Sankyo Co. Ltd. announced last month that it will restructure its subsidiary Asubio Pharma Co. Ltd. in April 2010 as a drug discovery venture business.
 
The restructuring is part of Daiichi Sankyo's plan to streamline its operations and includes intellectual property rights, late-stage clinical development and pharmaceutical technology research. Asubio and its 200 employees will be relocated in October 2010 to the site of the Kobe Medical Industry Development Project in Kobe, Japan. Asubio Pharma was formerly a pharmaceutical business division of Suntory Ltd., taking over all of its pharmaceutical businesses in December 2002. 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.